InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,380.40
(
0.30%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
75.01
(
1.72%
)
Bitcoin
63,541.83
(
0.34%
)
Post# of 125
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BollixMeArse

Send PM Follow Ignore
Followers 1
Posts 121
Boards Moderated 0
Alias Born 02/28/2013

BollixMeArse

Re: None

Wednesday, 12/04/2013 10:33:52 AM

Wednesday, December 04, 2013 10:33:52 AM

Post# of 125
Medgenics to Present at the Oppenheimer 24(th) Annual Healthcare Conference.

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--December 04, 2013--

Medgenics, Inc. (NYSE MKT:MDGN and AIM:MEDU, MEDG) (the Company), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that Company management will participate in the Oppenheimer 24(th) Annual Healthcare Conference taking place from December 10-11, 2013 in New York City.

Michael Cola, President and Chief Executive Officer of Medgenics, will present a corporate overview on Wednesday, December 11th at 4:30 p.m. Eastern time.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up